Author

C. A. Dinarello

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

C. Marchetti· 2 shared A. Dinarello· 1 shared A. Tesoriere· 1 shared D. M. de Graaf· 1 shared E. Z. Eisenmesser· 1 shared I. W. Tengesdal· 1 shared J. Amo-Aparicio· 1 shared J. M. Gaballa· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

C. Marchetti

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cell BiologybioRxivApr 4, 2023

IL-38 regulates intestinal stem cell homeostasis by inducing WNT signaling and beneficial IL-1beta secretion

A. Dinarello, M. May, J. Amo-Aparicio…·C. A. Dinarello

This paper shows IL-38 promotes intestinal stem cell growth by enhancing WNT signaling and beneficial IL-1beta secretion, while also having anti-inflammatory effects in the small intestine.

DOI 10.1073/pnas.2306476120

mouseproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintFeb 24, 2021

Targeting of the NLRP3 Inflammasome for early COVID-19

C. Marchetti, K. Mould, I. W. Tengesdal…·C. A. Dinarello

This study identifies early NLRP3 inflammasome activation in COVID-19 patients, linking it to cytokine release syndrome and suggesting NLRP3 as a therapeutic target.

DOI 10.1101/2021.02.24.432734

humanhost-pathogen & immune response

𝕏 PostBluesky